-
Sep 19, 2023, 08:56 AM
by
Full story
-
Sep 19, 2023, 08:56 AM
by
Ann Graham, Founder and Executive Director of MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to making it better for its community of patients, caregivers, doctors, and researchers, has officially joined the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Panel for Bone Cancer, in the role of patient advocate.
Full story
-
Sep 19, 2023, 08:56 AM
by
Full story
-
Sep 19, 2023, 08:56 AM
by
Full story
-
Sep 19, 2023, 08:56 AM
by
Full story
-
Sep 19, 2023, 01:00 AM
by
User Not Found
Bio-IT World | INNOVATIVE PRACTICES AWARDS—When City of Hope wanted to better use its primary and secondary clinical research data and harmonize files on more than 700,000 patients so they were findable and accessible, the hospital built a highly scalable, compliant cloud-based platform.
Full story
-
Sep 18, 2023, 08:53 AM
by
Full story
-
Sep 18, 2023, 08:53 AM
by
Full story
-
Sep 18, 2023, 08:53 AM
by
Leading downstream bioprocessing technology company, Verdot, announces the launch of its FlexiPro™ TFF, a multipurpose tangential flow filtration (TFF) GMP system, in response to rising industry demand for gene therapy, vaccine, and mRNA-based therapeutics.
Full story
-
Sep 15, 2023, 07:23 AM
by
Full story
-
Sep 15, 2023, 07:23 AM
by
Invitation to learn from the best: Evening of insights and networking will honor a clinical data management stalwart
Prof Deborah Ashby to give the 2023 Sally Hollis Memorial Lecture in Macclesfield
Full story
-
Sep 15, 2023, 07:23 AM
by
BRIM Biotechnology, Inc. (“BRIM,” TPEx 6885), a clinical-stage biotechnology company focusing on developing regenerative peptides for ophthalmology and degenerative joint diseases, announced today that 22,500 shares have been issued at a premium of NT$65 (~US$2.03), raising a total of NT$1.4625 billion (~US$45.8 million). The rights issue was fully paid on 31st August 2023, four days early compared to the scheduled date of 4th September.
Full story
-
Sep 15, 2023, 07:23 AM
by
Torx® Software Limited has launched a major international collaboration with CDD Vault, which will create a shared digital ecosystem for drug discovery data
Full story
-
Sep 15, 2023, 07:23 AM
by
SMi Systems has secured a patent from the UK Intellectual Property Office for the single-molecule imaging technologies that underpin its super-resolution multi-omic platform.
Full story
-
Sep 15, 2023, 07:23 AM
by
Central California Alliance for Health (CCAH), just announced they selected ZeOmega’s care management solution to support its 420,000+ Medi-Cal members, including those in the most vulnerable communities.
ZeOmega’s platform will enable CCAH to pinpoint the care needs of at-risk members and champion CalAIM’s efforts to provide equitable, person-centered care across California. This partnership also reflects the increased demand for flexible and scalable technology solutions to support government-sponsored healthcare programs across the nation.
Full story
-
Sep 15, 2023, 07:23 AM
by
Form Bio, the provider of advanced computational life sciences technology announced today capabilities for cell and gene therapy companies to rapidly model billions of potential construct candidates. With great progress to date but headwinds around safety and manufacturability, Form’s new solutions help therapy developers find the safest and highest yielding versions of their therapies.
Full story
-
Sep 15, 2023, 07:23 AM
by
Huateng Pharma will be attending CPhI Worldwide, Booth 3C02, Hall 3.
Full story
-
Sep 14, 2023, 01:00 AM
by
User Not Found
Bio-IT World | INNOVATIVE PRACTICES AWARDS—There are questions every research group could ask. At Regeneron’s Research and Preclinical department, tackling these questions meant accounting for more than 2,000 expensive and space-constrained instruments and seeking insight into how they are used.
Full story
-
Sep 13, 2023, 01:00 AM
by
User Not Found
Bio-IT World | Vaccine developers may want to consider designing formulations intended to prevent symptoms rather than infection, which the COVID-19 pandemic has demonstrated can be hard to do with any long-lasting effect.
Full story
-
Sep 12, 2023, 17:42 PM
by
Takara Bio Europe has announced the launch of new high-quality grade mRNA production enzymes suitable for pre-clinical and process development in mRNA vaccine and therapeutic manufacturing.
Full story